Aleen Khoury
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chemotherapeutic Potential of Fluorouracil-Platinum (IV) Prodrugs Against Cisplatin-Resistant Colorectal Cancer Cells.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: November 13, 2025
Potent anticancer 5-fluorouracil platinum(IV) prodrugs.
Journal: Journal of inorganic biochemistry
Published: September 28, 2025
The anti-neoplastic potency of epoxy-substituted polyaromatic platinum(II) and platinum(IV) complexes against A549 lung cancer cells.
Journal: European journal of medicinal chemistry
Published: March 06, 2025
Enhanced potency of a chloro-substituted polyaromatic platinum(II) complex and its platinum(IV) prodrug against lung cancer.
Journal: Chemico-biological interactions
Published: August 09, 2023
Novel Platinum(II) and Platinum(IV) Antitumor Agents that Exhibit Potent Cytotoxicity and Selectivity.
Journal: Journal of medicinal chemistry
Published: December 08, 2022
Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells.
Journal: Pharmaceutics
Published: September 28, 2022
Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity.
Journal: Pharmaceutics
Published: February 27, 2022
Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action.
Journal: Journal of inorganic biochemistry
Published: February 17, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026